Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCE: D-dimer Guiding Anticoagulation in Bioprosthetic Heart Valves
NCT03885180Unknown
- Sponsor
- Wuhan Asia Heart Hospital
- Start
- Mar 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of warfarin in thromboembolism (2 arms), sponsored by Wuhan Asia Heart Hospital. Primary endpoints: Thrombotic events at 24 months and Bleeding events at 24 months. Status: unknown.
02
Drugs
warfarin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT03885180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03885180.